Week of January 10th 2022 | Vol. 11, Issue 2
In This Issue
Upcoming Events
Industry M&A Activity
Recent Transactions
Trading Comps
Market Reports
M&A Pipeline
Featured Headlines
Tanner Updates

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory
Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to download complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners
Dates TBD - Charlotte, NC

January 10-13, 2022 - Attending Virtually
INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
M&A TRANSACTIONS
Pharma & Biotech
7 transactions totaling $852 million

Supplies, Equipment & Services
38 transactions totaling $195 million

Healthcare IT & Managed Care
15 transactions totaling $3,966

Healthcare Facilities & Distributors
22 transactions totaling $287 million
PRIVATE PLACEMENTS
Pharma & Biotech
38 transactions totaling $1,477 million

Supplies, Equipment & Services
22 transactions totaling $131 million

Healthcare IT & Managed Care
24 transactions totaling $313 million

Healthcare Facilities & Distributors
3 transactions totaling $5
PUBLIC OFFERINGS
Pharma & Biotech
3 transactions totaling $650 million

Supplies, Equipment & Services
3 transactions totaling $79 million

Healthcare IT & Managed Care
1 transaction totaling $23 million

Healthcare Facilities & Distributors
0 transactions
TRADING COMPS
A Breakdown of Relevant Trading Multiples
This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
MARKET REPORTS
Insight Into Healthcare Related Industries
M&A PIPELINE
Representative Current Retained Sell-Side And Partnering Opportunities
Project Alamo
Sell-side | CMO | Corporate Carve out - private label and OTC manufacturing business

Project Focus
Sell-side | CMO | Liquids and Semi-solids CMO headquartered in North America

Project Nucleus
Buy-side| CDMO | North American radiopharmaceutical company
Project Power Play
Buy-side | Specialty Pharma | In-license and acquire approved Rx products including legacy brands, generics, and niche launch-ready products

Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics
FEATURED HEADLINES
A Sampling of Industry Headlines From Last Week
The benchtop DNA printer developer DNA Script has expanded upon its most recent venture capital funding round, tacking on an additional $35 million for a grand total of $200 million. The financing will help promote the launch of its new systems.

In late October 2021, the company tallied up $165 million in a series C round co-led by Coatue Management and Catalio Capital Management. Other new investors in that nine-digit fundraising included Fidelity Management and Research, Columbia Threadneedle Investments, Arrowmark Partners, Farallon Capital and Moore Strategic Ventures.

Now with a second tranche of investors, DNA Script added T. Rowe Price, Baillie Gifford, HealthCor Management, eureKARE and Irving Investors.
Stryker inked a $3 billion deal to dramatically reshape its digital patient outreach efforts with the acquisition of Vocera Communications. The care coordination provider found new value during the COVID-19 pandemic, when clinicians and surgeons needed to find new ways to connect with their patients remotely and also to streamline their efforts to help meet the high demand for real-time, personal interactions.
Aetion, which offers a real-world evidence (RWE) data platform, has acquired artificial intelligence data specialist Replica Analytics for an undisclosed price. The deal gives Aetion technology that produces synthetic, privacy-protected copies of real-world data that maintain the integrity and utility of source data. 
Novo Holdings acquired South Carolina-based sterile injectables manufacturer Ritedose for an undisclosed price. Ritedose, which specializes in blow-fill-seal technology and has been focusing on the outsourced sterile compounding market for drugs in short supply, employs about 400 people at its Columbia, South Carolina, campus.
Novo Holdings and experienced venture capitalists on both sides of the Atlantic have come together to create a new fund focused on rare diseases. Led by VCs who spent years at Lundbeckfonden Ventures and NEA, Sound Bioventures will use its initial 110 million euros ($124 million) to back biotechs that are either in or on the cusp of the clinic.
We are looking for pharma professionals to join our expanding US and UK teams.